Ibandronatna kiselina Teva
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Ibandronatna kiselina Teva |
|---|---|
| Active Substance | natrijev ibandronat hidrat |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription (Ibandronic Acid Teva 50 mg) Medicinal product on medical prescription for renewable delivery (Ibandronic Acid Teva 150 mg) |
| Distribution | Supply through pharmacies (community) |
| ATC Code | M05BA06 |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
